Clinical trial
Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated…
NCT00236886 · Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry · Completed
Key facts
| NCT number | NCT00236886 |
|---|---|
| Title | Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients |
| Official title | Prospective Pilot Study on Metabolism and Weight Changes in Subjects With Diagnosed Partial Onset Epilepsy, With or Without Secondarily Generalized Seizures and Treated With Topiramate. |
| Lead sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy, Epilepsies, Partial, Generalized, Seizures |
| Intervention type | Drug |
| Interventions | topiramate |
| Enrollment | 49 |
| Start date | May 1, 1998 |
| Completion | Jun 1, 2000 |
| First posted | Oct 12, 2005 |
| Last update posted | Apr 28, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: